• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过亲和层析从正常动物和氯贝丁酯处理的动物中快速纯化胞质环氧化物水解酶。

Rapid purification of cytosolic epoxide hydrolase from normal and clofibrate-treated animals by affinity chromatography.

作者信息

Prestwich G D, Hammock B D

出版信息

Proc Natl Acad Sci U S A. 1985 Mar;82(6):1663-7. doi: 10.1073/pnas.82.6.1663.

DOI:10.1073/pnas.82.6.1663
PMID:3856846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC397332/
Abstract

Epoxide hydrolase from liver cytosol (cEH) of both normal and clofibrate-treated mice can be bioselectively adsorbed onto an affinity column prepared from epoxy-activated Sepharose and 7-methoxycitronellyl thiol. The free ligand is a modest inhibitor of cEH (I50, approximately equal to 3 X 10(-4) M) and lacks the epoxide function necessary for it to be turned over as a substrate. This study demonstrates that a methoxy group can be used to mimic an oxirane in a vertebrate system. Bioselective elution of cEH can be accomplished with several chalcone oxides, which are selective potent inhibitors (I50, 1-50 X 10(-7) M), and activity can be recovered by dialysis. This procedure thus enhances the purification by offering independent opportunities for selective binding and selective elution. Conservatively, a 40%-80% recovery of partially inhibited enzyme activity can be achieved in 4-48 hr with a 30- to 90-fold purification. The purified cEH from clofibrate-induced animals was essentially homogeneous by NaDodSO4/PAGE and had an apparent subunit molecular weight of 58,000. The cEHs from normal and clofibrate-induced animals appeared identical by NaDodSO4/PAGE. Since the cEH activity in normal and clofibrate-treated animals is due to the same enzyme, the increase in cEH activity caused by selected hypolipidemic agents appears to be true induction.

摘要

正常小鼠和用氯贝丁酯处理过的小鼠肝脏胞液中的环氧化物水解酶(cEH)都能被生物选择性地吸附到由环氧活化的琼脂糖和7-甲氧基香茅基硫醇制备的亲和柱上。游离配体是cEH的一种适度抑制剂(半数抑制浓度I50约为3×10⁻⁴ M),并且缺乏作为底物被转化所需的环氧化物官能团。这项研究表明,在脊椎动物系统中,甲氧基可用于模拟环氧乙烷。cEH的生物选择性洗脱可以用几种查尔酮氧化物来完成,这些查尔酮氧化物是选择性强效抑制剂(I50为1 - 50×10⁻⁷ M),并且活性可以通过透析恢复。因此,该方法通过提供选择性结合和选择性洗脱的独立机会来提高纯化效果。保守估计,在4 - 48小时内可实现部分抑制的酶活性40% - 80%的回收率,纯化倍数为30至90倍。用十二烷基硫酸钠聚丙烯酰胺凝胶电泳(NaDodSO4/PAGE)分析,从用氯贝丁酯诱导的动物中纯化得到的cEH基本均一,其亚基表观分子量为58,000。用NaDodSO4/PAGE分析,正常动物和用氯贝丁酯诱导的动物的cEH看起来是相同的。由于正常动物和用氯贝丁酯处理的动物中的cEH活性是由同一种酶引起的,所以某些降血脂药物引起的cEH活性增加似乎是真正的诱导作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c5b/397332/191169032b2c/pnas00346-0101-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c5b/397332/43985762f85b/pnas00346-0101-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c5b/397332/191169032b2c/pnas00346-0101-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c5b/397332/43985762f85b/pnas00346-0101-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c5b/397332/191169032b2c/pnas00346-0101-b.jpg

相似文献

1
Rapid purification of cytosolic epoxide hydrolase from normal and clofibrate-treated animals by affinity chromatography.通过亲和层析从正常动物和氯贝丁酯处理的动物中快速纯化胞质环氧化物水解酶。
Proc Natl Acad Sci U S A. 1985 Mar;82(6):1663-7. doi: 10.1073/pnas.82.6.1663.
2
Comparison of crude and affinity purified cytosolic epoxide hydrolases from hepatic tissue of control and clofibrate-fed mice.对照小鼠和氯贝丁酯喂养小鼠肝脏组织中粗提和亲和纯化的胞质环氧化物水解酶的比较。
Arch Biochem Biophys. 1986 Jan;244(1):292-309. doi: 10.1016/0003-9861(86)90119-0.
3
Properties of cytosolic epoxide hydrolase purified from the liver of untreated and clofibrate-treated mice. Purification procedure and physiochemical characterization of the pure enzymes.
Eur J Biochem. 1985 May 2;148(3):421-30. doi: 10.1111/j.1432-1033.1985.tb08856.x.
4
Human and murine cytosolic epoxide hydrolase: physical and structural properties.人和小鼠胞质环氧化物水解酶:物理和结构特性
Int J Biochem. 1990;22(5):461-70. doi: 10.1016/0020-711x(90)90258-5.
5
Concomitant induction of cytosolic but not microsomal epoxide hydrolase with peroxisomal beta-oxidation by various hypolipidemic compounds.各种降血脂化合物伴随过氧化物酶体β-氧化诱导胞质环氧水解酶而非微粒体环氧水解酶。
Biochem Pharmacol. 1987 Feb 1;36(3):345-51. doi: 10.1016/0006-2952(87)90292-9.
6
Affinity purification of cytosolic epoxide hydrolase using derivatized epoxy-activated Sepharose gels.
Anal Biochem. 1988 Feb 15;169(1):71-80. doi: 10.1016/0003-2697(88)90256-4.
7
Distribution and inducibility of cytosolic epoxide hydrolase in male Sprague-Dawley rats.雄性斯普拉格-道利大鼠胞质环氧化物水解酶的分布及诱导性
Biochem Pharmacol. 1986 Oct 1;35(19):3309-16. doi: 10.1016/0006-2952(86)90428-4.
8
Hepatic epoxide hydrolase activities and their induction by clofibrate and diethylhexylphthalate in various strains of mice.不同品系小鼠肝脏环氧水解酶活性及其受氯贝丁酯和邻苯二甲酸二(2-乙基己基)酯诱导的情况。
Biochem Pharmacol. 1987 Dec 15;36(24):4221-7. doi: 10.1016/0006-2952(87)90662-9.
9
Coordinate induction of peroxisomal beta-oxidation activity and cytosolic epoxide hydrolase activity.过氧化物酶体β-氧化活性与胞质环氧化物水解酶活性的协同诱导
Pharmacol Ther. 1987;33(1):29-35. doi: 10.1016/0163-7258(87)90024-6.
10
The regulation of cytosolic epoxide hydrolase in mice.小鼠胞质环氧化物水解酶的调控
Biochem Biophys Res Commun. 1985 Nov 27;133(1):233-8. doi: 10.1016/0006-291x(85)91866-2.

引用本文的文献

1
Development of multitarget agents possessing soluble epoxide hydrolase inhibitory activity.具有可溶性环氧化物水解酶抑制活性的多靶点药物的研发。
Prostaglandins Other Lipid Mediat. 2019 Feb;140:31-39. doi: 10.1016/j.prostaglandins.2018.12.003. Epub 2018 Dec 26.
2
The amino-terminal region of the adenovirus serotype 5 E1a protein performs two separate functions when expressed in primary baby rat kidney cells.当在新生大鼠肾原代细胞中表达时,腺病毒5型E1a蛋白的氨基末端区域发挥两种不同的功能。
Mol Cell Biol. 1988 Sep;8(9):3882-90. doi: 10.1128/mcb.8.9.3882-3890.1988.

本文引用的文献

1
STUDIES WITH ETHYL CHLOROPHENOXYISOBUTYRATE (CLOFIBRATE).氯贝丁酯(安妥明)的研究。
Metabolism. 1965 Sep;14:959-65. doi: 10.1016/0026-0495(65)90111-3.
2
Distribution and properties of a mammalian soluble epoxide hydrase.一种哺乳动物可溶性环氧化物水解酶的分布与特性
Biochem Pharmacol. 1980 Feb;29(3):389-95. doi: 10.1016/0006-2952(80)90518-3.
3
Cytosolic and microsomal epoxide hydrolases: differential properties in mammalian liver.胞质和微粒体环氧化物水解酶:哺乳动物肝脏中的差异特性。
Science. 1980 Mar 28;207(4438):1479-81. doi: 10.1126/science.7361100.
4
Angiotoxicity of oxygenated sterols and possible precursors.氧化甾醇及其可能的前体的血管毒性。
Science. 1980 Feb 8;207(4431):651-3. doi: 10.1126/science.7352277.
5
Epoxide hydrolase activity in the mitochondrial and submitochondrial fractions of mouse liver.小鼠肝脏线粒体及亚线粒体组分中的环氧水解酶活性
Biochem Pharmacol. 1981 Aug 1;30(15):2111-20. doi: 10.1016/0006-2952(81)90230-6.
6
The hepatic microsomal biotransformation of delta 5-steroids to 5 alpha, 6 beta-glycols via alpha- and beta-epoxides.
J Biol Chem. 1981 Mar 25;256(6):2900-7.
7
Characterization of cytosolic epoxide hydrolase in mouse liver.小鼠肝脏中胞质环氧化物水解酶的特性分析。
Acta Chem Scand B. 1982;36(8):549-51. doi: 10.3891/acta.chem.scand.36b-0549.
8
Purification and characterization of a soluble epoxide hydrolase from rabbit liver.兔肝可溶性环氧化物水解酶的纯化与特性分析
Eur J Biochem. 1982 Jul;125(2):457-61. doi: 10.1111/j.1432-1033.1982.tb06705.x.
9
Chalcone oxides--potent selective inhibitors of cytosolic epoxide hydrolase.查耳酮氧化物——胞质环氧化物水解酶的强效选择性抑制剂。
Arch Biochem Biophys. 1982 Jul;216(2):423-39. doi: 10.1016/0003-9861(82)90231-4.
10
Molecular properties and biological functions of microsomal epoxide hydrase.微粒体环氧化物水解酶的分子特性与生物学功能
Annu Rev Pharmacol Toxicol. 1980;20:513-31. doi: 10.1146/annurev.pa.20.040180.002501.